Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 93Leukemia 70Lymphoma 52Leukemia, Myeloid, Acute 41Burkitt Lymphoma 36Myelodysplastic Syndromes 32Lymphoma, Non-Hodgkin 27Hodgkin Disease 27Lymphoma, Mantle-Cell 24Leukemia, Lymphocytic, Chronic, B-Cell 23Recurrence 21Lymphoma, Large B-Cell, Diffuse 21Graft vs Host Disease 21Lymphoma, Follicular 19Congenital Abnormalities 18Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 17Multiple Myeloma 17Leukemia, Myeloid, Accelerated Phase 16Leukemia, Myelogenous, Chronic, BCR-ABL Positive 16Myeloproliferative Disorders 15Leukemia, Myelomonocytic, Chronic 15Blast Crisis 15Lymphoma, B-Cell, Marginal Zone 14Leukemia, Myeloid, Chronic-Phase 13Lymphoma, Large-Cell, Immunoblastic 12Hematologic Neoplasms 12Primary Myelofibrosis 11Lymphoma, Large-Cell, Anaplastic 11Breast Neoplasms 11Neoplasms, Plasma Cell 10

Interventions

Doxorubicin 5pazopanib 4Ifosfamide 3pembrolizumab 2Sunitinib 2Radiotherapy, Conformal 2Radiotherapy 2tremelimumab 1temsirolimus 1sintilimab 1saracatinib 1sapanisertib 1romidepsin 1olaratumab 1liposomal doxorubicin 1indolepropanol phosphate 1eribulin 1durvalumab 1Watchful Waiting 1Surgical Procedures, Operative 1Sorafenib 1Razoxane 1Radiotherapy, Intensity-Modulated 1Radiation 1Polymerase Chain Reaction 1Observation 1Nivolumab 1Neoadjuvant Therapy 1Methotrexate 1MLN 8237 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Histiocytoma, Malignant Fibrous × Methotrexate × Clear all
NCT00667342 2023-08-07

A Study of Bevacizumab in Combination With Chemotherapy for Treatment of Osteosarcoma

St. Jude Children's Research Hospital

Phase 2 Completed
43 enrolled 25 charts
Sarcoma

Osteosarcoma, Histiocytoma, Malignant Fibrous

Data powered by HemOnc (CC BY 4.0) Colophon âš¡